VIR - Vir Biotechnology, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - VIR (1706431)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear

79 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2021-06-16
VIRPang PhillipChief Medical OfficerS - Sale+OE$43.67-5,000109,277-4%-$218,346
D
2021-06-15
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$45.29-1,37591,700-1%-$62,274
2021-06-03
VIRMore Robert JDirS - Sale$44.56-11,670567,150-2%-$520,033
D
2021-06-02
VIRPang PhillipChief Medical OfficerS - Sale+OE$41.49-10,000109,277-8%-$414,874
D
2021-06-01
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$42.51-1,37591,700-1%-$58,451
2021-05-20
VIRMore Robert JDirS - Sale$44.50-11,670575,446-2%-$519,351
D
2021-05-19
VIRRamasastry SairaDirS - Sale+OE$43.73-10,0000-100%-$437,275
2021-05-19
VIRSato Vicki LDirS - Sale$43.80-15,1741,653,936-1%-$664,601
D
2021-05-18
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$45.03-1,37591,700-1%-$61,916
D
2021-05-04
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$46.03-1,37591,700-1%-$63,291
D
2021-04-27
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$49.50-7,90091,700-8%-$391,077
D
2021-04-19
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$48.00-2,34091,700-2%-$112,320
D
2021-04-13
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$43.57-5,56088,200-6%-$242,244
D
2021-04-01
VIRParrish JayChief Business OfficerS - Sale+OE$51.40-6,9449,260-43%-$356,956
D
2021-03-23
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$53.60-7,90074,200-10%-$423,408
D
2021-03-10
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$48.00-2,34074,200-3%-$112,320
D
2021-03-09
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$44.80-5,56074,200-7%-$249,086
D
2021-03-01
VIRParrish JayChief Business OfficerS - Sale+OE$63.44-6,9449,260-43%-$440,531
D
2021-02-23
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$63.74-7,90074,200-10%-$503,577
D
2021-02-09
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$71.16-7,90033,200-19%-$562,161
D
2021-02-01
VIRParrish JayChief Business OfficerS - Sale+OE$69.91-6,944222,222-3%-$485,424
D
2021-01-26
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$48.17-31,30033,200-49%-$1,507,806
D
2021-01-15
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$38.00-10,53033,200-24%-$400,140
D
2021-01-12
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$29.36-3,80533,200-10%-$111,696
D
2021-01-04
VIRParrish JayChief Business OfficerS - Sale+OE$26.32-6,945222,222-3%-$182,795
D
2020-12-22
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$31.19-3,80523,700-14%-$118,683
D
2020-12-08
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$31.27-3,80523,700-14%-$118,966
D
2020-12-01
VIRParrish JayChief Business OfficerS - Sale+OE$31.53-6,945222,222-3%-$218,968
D
2020-11-27
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$30.00-2,93023,700-11%-$87,900
D
2020-11-24
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$27.29-2,34023,700-9%-$63,848
D
2020-11-10
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$26.26-2,34023,700-9%-$61,448
D
2020-10-21
VIRPang PhillipChief Medical OfficerS - Sale+OE$31.44-5,00029,777-14%-$157,209
D
2020-11-02
VIRParrish JayChief Business OfficerS - Sale+OE$31.27-6,944222,222-3%-$217,153
D
2020-10-27
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$35.04-3,80523,700-14%-$133,335
D
2020-10-21
VIRPang PhillipChief Medical OfficerS - Sale+OE$35.49-12,50029,777-30%-$443,608
D
2020-10-13
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$43.03-5,56023,700-19%-$239,236
D
2020-10-07
VIRPang PhillipChief Medical OfficerS - Sale+OE$41.74-12,50029,777-30%-$521,795
D
2020-10-01
VIRParrish JayChief Business OfficerS - Sale+OE$34.75-6,945222,222-3%-$241,342
D
2020-09-29
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$38.00-3,51023,700-13%-$133,380
D
2020-09-22
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$31.71-3,80520,000-16%-$120,638
D
2020-09-16
VIRPang PhillipChief Medical OfficerS - Sale+OE$31.90-12,50029,777-30%-$398,694
D
2020-09-08
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$29.99-3,80520,000-16%-$114,098
D
2020-08-25
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$42.92-5,56020,000-22%-$238,632
D
2020-09-02
VIRPang PhillipChief Medical OfficerS - Sale+OE$32.89-12,50029,777-30%-$411,159
D
2020-09-01
VIRParrish JayChief Business OfficerS - Sale+OE$39.15-6,943222,222-3%-$271,796
D
2020-08-19
VIRPang PhillipChief Medical OfficerS - Sale+OE$50.95-12,50029,777-30%-$636,855
D
2020-08-11
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$51.08-7,9000-100%-$403,563
D
2020-08-05
VIRPang PhillipChief Medical OfficerS - Sale+OE$50.90-12,50015,777-44%-$636,222
D
2020-08-05
VIRPang PhillipChief Medical OfficerS - Sale+OE$50.90-12,50015,777-44%-$636,222
D
2020-08-03
VIRParrish JayChief Business OfficerS - Sale+OE$47.65-11,110222,222-5%-$529,404
D
2020-07-28
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$47.99-7,9000-100%-$379,090
D
2020-07-28
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$47.99-7,9000-100%-$379,090
D
2020-07-14
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$48.85-7,9000-100%-$385,876
D
2020-07-15
VIRPang PhillipChief Medical OfficerS - Sale+OE$49.53-12,50015,777-44%-$619,118
2020-07-13
VIRHorn HowardCFOS - Sale$50.06-30,000177,777-14%-$1,501,731
D
2020-07-01
VIRParrish JayChief Business OfficerS - Sale+OE$37.95-75,000222,222-25%-$2,846,310
D
2020-07-01
VIRPang PhillipChief Medical OfficerS - Sale+OE$37.78-12,50015,777-44%-$472,252
M
2020-07-01
VIRHorn HowardCFOS - Sale$38.92-20,000207,777-9%-$778,399
2020-06-25
VIRHorn HowardCFOS - Sale$50.00-30,000227,777-12%-$1,500,000
DM
2020-06-23
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$44.64-14,9200-100%-$666,058
2020-06-19
VIRHorn HowardCFOS - Sale$40.00-10,000257,777-4%-$400,000
D
2020-06-19
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$38.00-3,5100-100%-$133,384
D
2020-06-17
VIRPang PhillipChief Medical OfficerS - Sale+OE$37.27-12,50015,777-44%-$465,815
D
2020-06-09
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$36.28-3,8050-100%-$138,030
D
2020-06-03
VIRPang PhillipChief Medical OfficerS - Sale+OE$35.07-12,50015,777-44%-$438,387
D
2020-06-01
VIRParrish JayChief Business OfficerS - Sale+OE$35.22-75,000222,222-25%-$2,641,410
2020-06-01
VIRHorn HowardCFOS - Sale$35.10-10,000267,777-4%-$351,038
D
2020-05-26
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$34.08-3,8050-100%-$129,674
D
2020-05-18
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$38.00-1,7550-100%-$66,690
D
2020-05-14
VIRVirgin HerbertEVP, Research, CSOS - Sale+OE$30.07-3,8050-100%-$114,418
D
2020-05-14
VIRParrish JayChief Business OfficerS - Sale+OE$30.05-75,000222,222-25%-$2,253,885
2020-05-01
VIRMore Robert JDirS - Sale$28.00-18,4581,043,755-2%-$516,853
D
2019-10-16
VIRBurow KristinaDirP - Purchase$20.00+1,000,0001,000,000New+$20,000,000
D
2019-10-16
VIRNelsen RobertDir, 10%P - Purchase$20.00+1,000,0001,000,000New+$20,000,000
D
2019-10-16
VIRArch Venture Partners Ix, LLC10%P - Purchase$20.00+1,000,0001,000,000New+$20,000,000
D
2019-10-16
VIRTemasek Holdings (Private) Ltd10%P - Purchase$20.00+500,0005,499,999+10%+$10,000,000
D
2019-10-16
VIRAbu Dhabi Investment AuthorityFormer 10% OwnerP - Purchase$20.00+1,000,0003,666,666+38%+$20,000,000
D
2019-10-16
VIRSvf Endurance (Cayman) Ltd10%P - Purchase$20.00+950,00022,616,666+4%+$19,000,000
D
2019-10-16
VIRAlaska Permanent Fund Corp10%P - Purchase$20.00+1,500,00016,666,668+10%+$30,000,000

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top